Blockchain Registration Transaction Record

Neutrophil Traps Drive Reperfusion Injury Across Organs

New review reveals neutrophils and NETs as key drivers of ischaemia–reperfusion injury across organs, highlighting biomarkers and therapeutic targets for heart attack, stroke, and transplant patients.

This news matters because ischaemia–reperfusion injury affects millions of patients undergoing treatment for heart attacks, strokes, organ transplants, and severe trauma. Understanding the role of NETs opens the door to new biomarkers and targeted therapies that could protect organs when blood flow is restored, potentially improving survival and reducing long-term disability. For patients, this could mean better outcomes with fewer complications, while for clinicians, it offers a roadmap for developing safer, more effective treatments that avoid broad immune suppression.